02:38:07 Europe / Stockholm

Prenumeration

2024-08-23 12:32:00

[ingress]

  • Letter of intent with a leading chemical company
  • License agreement with Chematur Engineering regarding PHBV
  • We keep our fair value of SEK 7.60 per share

During Q2, Bioextrax's project advanced. The company has entered into a license agreement with Chematur Engineering AB. After the quarter, the company also signed a letter of intent with a leading chemical company regarding mcl-PHA. Financially, the company follows its plan and the report did not prompt any major changes in our model. We keep our fair value of SEK 7.60 per share. The full report is available here.